Current status of contrast-induced nephropathy and nephrogenic systemic fibrosis in children

Pediatric Radiology

Volumn 39, Issue SUPPL. 3, 2009, Pages

  Karcaaltincaba, Musturay ^a   Oguz, Berna ^a   Haliloglu, Mithat ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GADOLINIUM; IODINATED CONTRAST MEDIUM; IODINE;

COMPUTED TOMOGRAPHIC ANGIOGRAPHY; GLOMERULUS FILTRATION RATE; KIDNEY DISEASE; KIDNEY FUNCTION; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; REVIEW;

CHILD; CONTRAST MEDIA; DIAGNOSTIC IMAGING; HUMANS; KIDNEY FAILURE, ACUTE; NEPHROGENIC FIBROSING DERMOPATHY; PEDIATRICS;

EID: 65649136519     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-009-1236-3     Document Type: Review

References (44)

1. CK Rigsby E Eric Gasber R Seshadri 2007 safety and efficacy of pressure-limited power injection of iodinated contrast medium through central lines in children AJR 188 726 732 (Pubitemid 46303197)
2. B Oguz M Haliloglu M Karcaaltincaba 2007 Paediatric multidetector CT angiography: spectrum of congenital thoracic vascular anomalies Br J Radiol 80 376 383 (Pubitemid 47315853)
3. DP Frush 2008 Pediatric abdominal CT angiography Pediatr Radiol 38 Suppl 2 S259 S266
4. RC Brasch 2008 Contrast media toxicity in children Pediatr Radiol 38 Suppl 2 S281 S284
5. S Fitoz N Unsal M Tekin 2007 Contrast-enhanced MR angiography of thoracic vascular malformations in children Int J Cardiol 123 3 11 (Pubitemid 350116981)
6. BR Herts E Schineider ED Poggio 2008 Identifying outpatients with renal insufficiency before contrast-enhanced CT by using estimated glomerular filtration rates versus serum creatinine levels Radiology 248 106 113
7. RA Halvorsen 2008 Which study when? Iodinated contrast-enhanced CT versus gadolinium-enhanced MR imaging Radiology 249 9 15
8. JC Weinreb 2008 Which study when? Is gadolinium-enhanced MR imaging safer than iodine-enhanced CT? Radiology 249 3 8
9. HS Thomsen 2007 Current evidence on prevention and management of contrast-induced nephropathy Eur Radiol 17 Suppl 6 F33 F37
10. M Cohen 2008 What is the normal serum creatinine concentration in children? Pediatr Radiol 38 1265
11. R Bessell-Browne ME O'Malley 2007 CT of pheochromocytoma and paraganglioma: risk of adverse events with i.v administration of nonionic contrast material. AJR 188 970 974
12. MR Prince HE Erel RW Lent 2003 Gadodiamide administration causes spurious hypocalcemia Radiology 227 639 646 (Pubitemid 36583017)
13. J Emerson G Kost 2004 Spurious hypocalcemia after Omniscan- or OptiMARK-enhanced magnetic resonance imaging: an algorithm for minimizing a false-positive laboratory value Arch Pathol Lab Med 128 1151 1156 (Pubitemid 39313370)
14. P Haage T Schmitz-Rode D Hübner 2000 Reduction of contrast material dose and artifacts by a saline flush using a double power injector in helical CT of the thorax AJR 174 1049 1053 (Pubitemid 30180001)
15. PJ Dorio FT Lee Jr KP Henseler 2003 Using a saline chaser to decrease contrast media in abdominal CT AJR 180 929 934 (Pubitemid 36363027)
16. M Karcaaltincaba D Foley 2005 Four- and eight-channel aortoiliac CT angiography: a comparative study Cardiovasc Intervent Radiol 28 169 172 (Pubitemid 40754802)
17. M Karcaaltincaba U Aydingoz D Akata 2004 Combination of extremity computed tomography angiography and abdominal imaging in patients with musculoskeletal tumors J Comput Assist Tomogr 28 273 277 (Pubitemid 38364995)
18. K Juluru J Vogel-Claussen KJ Macura 2009 MR imaging in patients at risk for developing nephrogenic systemic fibrosis: protocols, practices, and imaging techniques to maximize patient safety Radiographics 29 9 22
19. MS Nural E Gokce M Danaci 2008 Focal liver lesions: whether a standard dose (0.05 mmol/kg) gadobenate dimeglumine can provide the same diagnostic data as the 0.1 mmol/kg dose Eur J Radiol 66 65 74
20. BM Elicker YS Cypel JC Weinreb 2006 IV contrast administration for CT: a survey of practices for the screening and prevention of contrast nephropathy AJR 186 1651 1658 (Pubitemid 46112529)
21. M Brezis S Rosen 1995 Hypoxia of the renal medulla-its implications for disease N Engl J Med 332 647 655
22. JH Newhouse D Kho QA Rao 2008 Frequency of serum creatinine changes in the absence of iodinated contrast material: implications for studies of contrast nephrotoxicity AJR 191 376 382
23. RJ Bruce A Djamali K Shinki 2009 Background fluctuation of kidney function versus contrast-induced nephrotoxicity AJR 192 711 718
24. SK Morcos MF Bellin HS Thomsen 2008 Reducing the risk of iodine-based and MRI contrast media administration: recommendation for a questionnaire at the time of booking Eur J Radiol 66 225 229
25. J Perez-Rodriguez S Lai BD Ehst 2009 Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment-report of 33 cases Radiology 250 371 377
26. SE Cowper HS Robin SM Steinberg 2000 Scleromyxoedema-like cutaneous diseases in renal-dialysis patients Lancet 356 1000 1001
27. T Grobner 2006 Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? Nephrol Dial Transplant 21 1104 1108
28. P Marckmann L Skov K Rossen 2006 Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging J Am Soc Nephrol 17 2359 2362 (Pubitemid 44300951)
29. HS Thomsen P Marckmann 2008 Extracellular Gd-CA: differences in prevalence of NSF Eur J Radiol 66 180 183
30. MR Prince H Zhang M Morris 2008 Incidence of nephrogenic systemic fibrosis at two large medical centers Radiology 248 807 816
31. CD Wiginton B Kelly A Oto 2008 Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue AJR 190 1060 1068
32. U Aydingoz 2006 The need for radiologists' awareness of nephrogenic systemic fibrosis Diagn Interv Radiol 12 161 162 (Pubitemid 46017307)
33. R Wertman E Altun DR Martin 2008 Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities Radiology 248 799 806
34. EA Sadowski LK Bennett MR Chan 2007 Nephrogenic systemic fibrosis: risk factors and incidence estimation Radiology 243 148 157 (Pubitemid 46579705)
35. DR Martin 2008 Nephrogenic systemic fibrosis Pediatr Radiol 38 Suppl 1 S125 S129
36. SM Jain S Wesson A Hassanein 2004 Nephrogenic fibrosing dermopathy in pediatric patients Pediatr Nephrol 19 467 470 (Pubitemid 38477417)
37. VR Dharnidharka SK Wesson RS Fennell 2007 Gadolinium and nephrogenic fibrosing dermopathy in pediatric patients Pediatr Nephrol 22 1395 (Pubitemid 47054936)
38. D Kadiyala DA Roer MA Perazella 2009 Nephrogenic systemic fibrosis associated with gadoversetamide exposure: treatment with sodium thiosulfate Am J Kidney Dis 53 133 137
39. A Kreuter T Gambichler SM Weiner 2008 Limited effects of UV-A1 phototherapy in 3 patients with nephrogenic systemic fibrosis Arch Dermatol 144 1527 1529
40. S Chandran J Petersen C Jacobs 2009 Imatinib in the treatment of nephrogenic systemic fibrosis Am J Kidney Dis 53 129 132
41. M Panesar S Banerjee GW Barone 2008 Clinical improvement of nephrogenic systemic fibrosis after kidney transplantation Clin Transplant 22 803 808
42. J Kay WA High 2008 Imatinib mesylate treatment of nephrogenic systemic fibrosis Arthritis Rheum 58 2543 2548
43. KL Duffy L Green R Harris 2008 Treatment of nephrogenic systemic fibrosis with Re-PUVA J Am Acad Dermatol 59 2 Suppl 1 S39 S40
44. M Karcaaltincaba WD Foley 2002 Gadolinium-enhanced multidetector CT angiography of the thoracoabdominal aorta J Comput Assist Tomogr 26 875 878 (Pubitemid 36076698)